Table V.
Comparison of TEG parameters between treatment groups of diabetic nephropathy with SCI.
| Groups | Treatment | R (min) | K (min) | α-angle (°) | MA (mm) | G (kDa) | CI |
|---|---|---|---|---|---|---|---|
| A (n=50) | Pretherapy | 4.04±0.82 | 1.20±0.19 | 72.15±8.91 | 75.06±5.46 | 12.30±1.42 | 2.93±0.52 |
| Post-treatment | 6.20±0.84b | 1.96±0.23b | 63.22±9.04b | 70.40±5.35b | 10.12±1.38b | 1.85±0.32b | |
| B (n=50) | Pretherapy | 4.05±0.86 | 1.21±0.20 | 72.00±9.00 | 75.00±5.62 | 11.93±1.67 | 2.94±0.50 |
| Post-treatment | 6.78±0.32a,b | 2.28±0.19a,b | 60.38±9.21a,b | 66.90±5.93a,b | 8.62±1.62a,b | 1.56±0.39a,b |
Values are given as mean ± standard deviation or number.
a
P<0.05, group A vs. group B
b
P<0.05, pretherapy vs. post-treatment. TEG, thromboelastogram; SCI, silent cerebral infarction; R, reaction time; K, clotting time; MA, maximum amplitude; G, clot strength; CI, coagulation index.